Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
Author(s) -
Lei Tian,
Jie Gao,
Jianqiang Hao,
Yu Zhang,
Huimin Yi,
Timothy D. O’Brien,
Robert L. Sorenson,
Jianbin Luo,
Zhiguang Guo
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.95.6.9988
Subject(s) - dipeptidyl peptidase 4 , dipeptidyl peptidase , diabetes mellitus , inflammation , medicine , dipeptidyl peptidase 4 inhibitor , replication (statistics) , endocrinology , biology , type 2 diabetes , enzyme , virology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom